Glyvas 10MG Tab

Tablet

Type 2 diabetes mellitus (to help control blood glucose), usually as an add-on to diet and exercise; may be used alone or with other antidiabetic medicines as prescribed.

Vildagliptin is a DPP-4 inhibitor that increases levels of incretin hormones (GLP-1 and GIP). This enhances glucose-dependent insulin release and reduces glucagon secretion, lowering blood sugar with a low risk of hypoglycaemia when used alone.

Tablet for oral use. Take exactly as prescribed, at the same time each day, with or without food. Swallow whole with water; do not crush/chew unless advised. Continue diet/exercise and monitor blood glucose as directed.

Headache, dizziness, nausea, abdominal pain, diarrhoea, constipation, upper respiratory tract infection symptoms, tremor (more likely with other antidiabetics), hypoglycaemia (when combined with insulin/sulfonylureas)

Use with caution in kidney or liver disease; periodic liver function tests may be advised. Stop and seek medical help if symptoms of pancreatitis occur (severe persistent abdominal pain), or if allergic reactions/skin blistering occur. Risk of hypoglycaemia increases when combined with insulin or sulfonylureas—dose adjustment may be needed. Not a substitute for insulin in type 1 diabetes or diabetic ketoacidosis. Inform doctor if you have heart failure history.

Insulin and sulfonylureas (increased hypoglycaemia risk), ACE inhibitors (rare risk of angioedema reported with DPP-4 inhibitors), other antidiabetic medicines (additive glucose-lowering), drugs affecting liver function (monitoring advised)

Store below 25°C in a cool, dry place. Protect from moisture and direct light. Keep out of reach of children.

Galvus 50 Tablet, Zomelis 50 Tablet, Jalra 50 Tablet, Vilda 50 Tablet, Vildagliptin 50 mg Tablet (generic)